New
Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Advertisement
Advertisement
IBBQvsETF 2ETF Comparison
Choose a second ETF to run a side-by-side ETF comparison with IBBQ, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
IBBQ performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 03/11/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | IBBQ ETF 2 | -0.23%– | +3.22%– | +3.54%– | +33.90%– | +50.91%– | n/a– |
| Flows | IBBQ ETF 2 | +$2M– | +$13M– | +$8M– | +$21M– | +$41M– | -– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | IBBQ ETF 2 | +19.87%– | +22.98%– | +19.25%– | n/a– |
| Max drawdown | IBBQ ETF 2 | -4.51%– | -17.24%– | -23.78%– | n/a– |
| Max drawdown duration | IBBQ ETF 2 | 15d– | 127d– | 375d– | n/a– |
Trading data
IBBQ | ETF 2 | |
Last sale 3/11/2026 at 7:59 PM | $29.38 | – |
| Previous close 03/11/2026 | $29.56 | – |
| Consolidated volume 03/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of February 27, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
IBBQ | ETF 2 | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 3/11/2026 at 7:59 PM
Live
Closed
IBBQ | ETF 2 | |
|---|---|---|
| Last price | $29.38 | – |
| 1D performance | -0.61% | – |
| AuM | $74.04 M | – |
| E/R | 0.19% | – |
Characteristics
IBBQ | ETF 2 | |
|---|---|---|
| Management strategy | Passive | – |
| Provider | Invesco | – |
| Benchmark | NASDAQ Biotechnology Index | – |
| N° of holdings | 196 | – |
| Asset class | Equities | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 9, 2021 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
IBBQ
USA
93.84%
Other
6.16%
ETF 2
Sectors
IBBQ
Health Care
85.82%
Other
14.18%
ETF 2
Advertisement
Diversification
IBBQ
Total weight of top 15 holdings out of 15
52.08%
ETF 2
–
Top 15 holdings
Data as of January 31, 2026
IBBQ
VERTEX PHARMACEUTICALS
8.96%
GILEAD SCIENCES
8.92%
AMGEN-T
8.25%
REGENERON PHARMACEUTICALS
5.90%
ALNYLAM PHARMACEUTICALS
3.58%
INSMED
2.55%
BIOGEN INC
1.90%
US04016X1019
1.82%
ILLUMINA
1.75%
UTD THERAPEUT
1.53%
INCYTE
1.51%
REVOLUTION MEDICINES INC
1.42%
MODERNA INC
1.41%
ROYALTY PHARMA
1.30%
MEDPACE HOLDINGS INC
1.27%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
Advertisement
The Active Trader Report
Active Trader Report: Use of Leveraged & Inverse ETFs Way Up
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
